PACS Q1 2026 Earnings Call Summary | Stock Taper
Logo
PACS

PACS — PACS Group, Inc.

NYSE


Q1 2026 Earnings Call Summary

May 12, 2026

PACS Group Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

  • Revenue: $1.42 billion, an 11% increase year-over-year.
  • Net Income: $80.7 million, up from $28.5 million in Q1 2025.
  • Adjusted EBITDA: $170.4 million, a 75% increase from the previous year.
  • Adjusted EBITDAR: $265.9 million.
  • Diluted Earnings Per Share: $0.50, compared to $0.17 in the prior year.
  • Occupancy Rate: 90.9% across all facilities, up from 89.2% year-over-year.
  • Skilled Mix: Increased to 30.5%, up 90 basis points year-over-year.
  • Cost of Services: $1.07 billion, a 5% increase year-over-year, indicating operating leverage.

2. Strategic Updates and Business Highlights

  • PACS operates 323 facilities across 17 states, with a focus on integrating newly acquired facilities into their operational model.
  • 222 facilities received 4 or 5-star ratings under CMS Quality Measure ratings, up from 207 at the end of 2025.
  • The company emphasizes a locally led, centrally supported model to enhance patient care and operational consistency.
  • Investment in leadership development continues, with 40 administrators in training to support future growth.
  • The company is actively pursuing a robust pipeline of acquisition opportunities while maintaining a conservative balance sheet, with $800 million in available liquidity.

3. Forward Guidance and Outlook

  • Adjusted EBITDA Guidance: Increased to $605 million to $625 million for 2026, reflecting stronger-than-expected Q1 performance.
  • Revenue Guidance: Reaffirmed at $5.65 billion to $5.75 billion, excluding contributions from future acquisitions.
  • The company anticipates continued organic growth driven by strong occupancy and skilled mix trends.

4. Challenges and Points of Concern

  • Ongoing government investigations are still in progress, with no estimated resolution timeline provided.
  • The discontinuation of California's W Equip program may impact future revenue from quality incentive payments, although two additional payments from the 2025 program are expected.
  • Concerns regarding managed care providers potentially reducing admissions into skilled nursing facilities were acknowledged, though PACS has not yet seen an impact on its metrics.

5. Notable Q&A Insights

  • Management discussed ongoing negotiations with state Medicaid departments regarding quality incentive programs, particularly in Ohio, where they expect potential payouts.
  • The labor market is showing positive trends, with increased job applications and improved relationships with labor unions in California.
  • The company is focusing on maintaining a strong capital allocation strategy, including a $250 million share repurchase authorization to act opportunistically.
  • Management emphasized the importance of quality care in securing managed care contracts and highlighted the positive trajectory of their ramping facilities as they mature.

Overall, PACS Group reported strong financial performance in Q1 2026, with solid growth metrics and a clear strategy for continued operational improvement and expansion, despite facing some regulatory and market challenges.